Eagle Claw Capital Managment, LLC Teva Pharmaceutical Industries LTD Transaction History

Eagle Claw Capital Managment, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $171,432 - $280,120	-11,750 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $2,106 - $2,565	-100 Reduced 0.84%	11,750 $253,000
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $8,385 - $12,355	-500 Reduced 4.05%	11,850 $287,000
Q1 2018 May 18, 2018	SELL	$16.68 - $22.07 $20,016 - $26,484	-1,200 Reduced 8.86%	12,350 $212,000
Q4 2017 Feb 13, 2018	SELL	$11.23 - $19.1 $21,617 - $36,767	-1,925 Reduced 12.44%	13,550 $258,000
Q3 2017 Nov 16, 2017	SELL	$15.41 - $32.17 $15,410 - $32,170	-1,000 Reduced 6.07%	15,475 $271,000
Q2 2017 Aug 15, 2017	BUY	N/A	16,475	16,475 $545,000

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.